Vanguard Group Inc Opti Nose, Inc. Transaction History

Vanguard Group Inc

$4.96 Trillion
Q1 2024

A detailed history of Vanguard Group Inc transactions in Opti Nose, Inc. stock. As of the latest transaction made, Vanguard Group Inc holds 4,242,610 shares of OPTN stock, worth $4.37 Million. This represents 0.0% of its overall portfolio holdings.

Number of Shares

4,242,610

Previous 4,179,704 1.51%

Holding current value

$4.37 Million

Previous $5.39 Million 14.9%

% of portfolio

0.0%

Previous 0.0%

12 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2024 May 10, 2024	BUY	$1.17 - $1.94 $73,600 - $122,037	62,906 Added 1.51%	4,242,610 $6.19 Million
Q4 2023 Feb 14, 2024	BUY	$1.02 - $1.47 $365,395 - $526,599	358,231 Added 9.37%	4,179,704 $5.39 Million
Q3 2023 Nov 14, 2023	BUY	$0.93 - $1.38 $211,622 - $314,020	227,551 Added 6.33%	3,821,473 $4.7 Million
Q2 2023 Aug 14, 2023	BUY	$1.11 - $2.05 $497,880 - $919,509	448,541 Added 14.26%	3,593,922 $4.42 Million
Q1 2023 May 15, 2023	SELL	$1.63 - $2.02 $1,367 - $1,694	-839 Reduced 0.03%	3,145,381 $6.07 Million

Q4 2022 Feb 10, 2023	BUY	$1.68 - $3.7 $1.78 Million - $3.92 Million	1,058,184 Added 50.68%	3,146,220 $5.82 Million
Q3 2022 Nov 14, 2022	BUY	$3.43 - $4.01 $286,230 - $334,630	83,449 Added 4.16%	2,088,036 $7.64 Million
Q2 2022 Aug 12, 2022	BUY	$1.76 - $3.82 $194,150 - $421,395	110,313 Added 5.82%	2,004,587 $7.34 Million
Q1 2022 May 13, 2022	SELL	$1.77 - $2.93 $873,084 - $1.45 Million	-493,268 Reduced 20.66%	1,894,274 $4.68 Million
Q4 2021 Feb 14, 2022	BUY	$1.55 - $3.1 $1.3 Million - $2.61 Million	841,344 Added 54.41%	2,387,542 $3.87 Million
Q3 2021 Nov 12, 2021	BUY	$2.35 - $3.16 $16,633 - $22,366	7,078 Added 0.46%	1,546,198 $4.64 Million
Q2 2021 Aug 13, 2021	BUY	$2.91 - $3.83 $4.48 Million - $5.89 Million	1,539,120 New	1,539,120 $4.79 Million

Others Institutions Holding OPTN

# of Institutions

Shares Held

59.6M

Call Options Held

Put Options Held

View Full List

About OptiNose, Inc.

Ticker OPTN
Exchange NASDAQ
Sector Healthcare
Industry Drug Manufacturers—Specialty & Generic
Shares Outstandng 83,277,504
Market Cap $85.8M
Description
OptiNose, Inc., a specialty pharmaceutical company, focuses on the development and commercialization of products for patients treated by ear, nose, throat, and allergy specialists in the United States. The company offers XHANCE, a therapeutic product utilizing its proprietary exhalation delivery system (EDS) that delivers a topically-acting cort...

More about OPTN

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Vanguard Group Inc, based on Form 13F filings with the SEC.

News

Stay updated on Vanguard Group Inc with notifications on news.

Account

Vanguard Group Inc Opti Nose, Inc. Transaction History